The professional society — which was named as a defendant in many of the lawsuits filed by state and city governments over the opioid crisis — said its financial problems were exacerbated by the mounting legal expenses from defending the lawsuits.
“The society’s precarious financial position had been compounded and complicated by spurious lawsuits and subpoenas. Despite our best efforts to negotiate and collaborate on getting dismissal of these lawsuits, APS has been unable to accomplish that and remains subject to current and potential future litigation. This, combined with the declining membership and meeting attendance, has created the perfect storm,” the APS board wrote to its members, according to STAT.
A decision on the bankruptcy filing is expected May 28.
More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer